Purchase Order SPE2DP23P0721
Award Date 8/16/23
Potential Completion Date 8/31/23
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,014.52, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a DILUTING SOLUTION,F product, which is likely a specialized medical supply or consumable used in healthcare or biomedical research applications. The contract is a firm fixed-price purchase order with no set-aside designation, indicating Fenwal's competitive capabilities in the...
- This federal contract award, valued at $3,297.19, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of a Diluting Solution, which is a specialized medical supply that supports healthcare and biomedical research initiatives. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Fenwal's competitive capabilities in the federal procurement...
- This federal contract award is for the procurement of a DILUTING SOLUTION,F product by the U.S. government. The contract was awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract has a firm fixed price of $1,519.68 and an ultimate completion date of May 20, 2025. It was awarded by the Defense Logistics Agency (DLA), which supports the defense and civilian medical supply chains. Fenwal, Inc. is a registered...
- This federal contract award, valued at $1,486.54, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is for the supply of "WASHING SOLUTION,FR" and is a firm fixed-price purchase order with a completion date of July 23, 2025. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007, and has...
- This federal contract award, valued at $18,378.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various blood collection supplies, including blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing strippers, plasma extractors, blood pack sealers, and centrifuging bags. The contract has an ultimate completion date...
- This federal contract award, valued at $1,839.04, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of blood packs with anticoagulant (8510030842) and has a completion date of August 14, 2023. Fenwal, a registered federal vendor since 2007, has a strong track record of supporting the U.S. government's healthcare and research initiatives by providing a diverse array...
- This federal contract award was issued by the Defense Logistics Agency, an agency within the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $1,081.12 firm fixed-price purchase order is for the delivery of WASHING SOLUTION,FR, a specialized medical supply used in healthcare and biomedical research applications. The contract has a completion date of February 13, 2025 and does not include a set-aside designation, reflecting...
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
- This federal contract award, valued at $1,316.91, was issued by the Defense Logistics Agency Troop Support Medical (DLA Troop Support) to Fenwal, Inc., a subsidiary of Fresenius Kabi and a registered vendor with the U.S. federal government since 2007. The contract is for the supply of various blood collection, separation, storage, and transfusion products, including donor tubing strippers, to support critical healthcare and research initiatives for government agencies such as the Department of...
- This federal contract award, valued at $2,852.72, was made by the Defense Logistics Agency Troop Support Medical (DLA Troop Support) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside designation,...
This federal contract award, valued at $1,975.92, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of 8510072100 - DILUTING SOLUTION,F, a medical supply item. The contract has a period of performance through August 31, 2023 and is a firm fixed-price purchase order. Fenwal, Inc. is a registered vendor with the U.S. federal government, providing a wide range of products and services to support critical healthcare and research initiatives, including the U.S. military's frozen blood program and biomedical research. This contract award does not have a set-aside designation.
Generated 9/7/24, 11:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/16/23 |